Evidence of this dysfunction includes a study looking at bone marrow-derived mesenchymal stem cells from 7 MDS patients (compared with healthy controls) that revealed an upregulation of IFN-α/β signaling and ISG15 in the MDS-derived samples [64]. The gene discussed is IFNA1; the disease is myelodysplastic syndrome.